53723 Guselkumab improves moderate-to-severe psoriasis and patient satisfaction leading to high patient benefit in a real-life setting: Results from the G-EPOSS study through Week 76

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2024-09, Vol.91 (3), p.AB223-AB223
Main Authors: Gerdes, Sascha, Zimmer, Sebastian, Schwinn, Andreas, Ostendorf, Rolf, Jacobsen, Simmy, Makuc, Judita, Trenkler, Nina, Behrens, Juliane, Tabori, Sarah, Mortazawi, Dariusch
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0190-9622
DOI:10.1016/j.jaad.2024.07.886